An antibody–toxin conjugate enhances innate immune cell responses in tumors

An antibody–toxin conjugate enhances innate immune cell responses in tumors An antibody–toxin conjugate enhances innate immune cell responses in tumors


Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Schrank, B. R. et al. An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nat. Cancer https://doi.org/10.1038/s43018-025-00919-0 (2025).




Source link

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use